Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 26, 2012Clinical Cancer ResearchOpen Access

The Use and Interpretation of Competing Risks Regression Models

View Full Paper
Ask AI
Bookmark
Share

Authors

JDJames J. DignamQZQiang ZhangMKMasha Kocherginsky

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dignam et al. (2012) studied this question.

synapsesocial.com/papers/69d99fefe6ab964fb0836006https://doi.org/10.1158/1078-0432.ccr-11-2097
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data1993 · 479 citations
  2. 2Semiparametric Models for Cumulative Incidence Functions2004 · 45 citations
  3. 3Understanding competing risks: a simulation point of view2011 · 96 citations
  4. 4The influence of competing-risks setting on the choice of hypothesis test for treatment effect2006 · 38 citations
  5. 5Misspecified regression model for the subdistribution hazard of a competing risk2006 · 88 citations